OBJECTIVE: Vitamin D deficiency is highly prevalent in high-risk patient populations, but the prevalence among otherwise healthy adults is less well-defined. The goal of this study was to determine the prevalence and predictors of low 25-hydroxyvitamin D [25(OH)D] levels in healthy younger adults. METHODS: This was a cross-sectional study of 634 healthy volunteers aged 18-50 years performed between January, 2006 and May, 2008. We measured serum 25(OH)D and parathyroid hormone and recorded demographic variables including age, sex, race, and use of multivitamin supplements. RESULTS: Thirty-nine percent of subjects had 25(OH)D ≤ 20 ng/mL and 64% had 25(OH)D ≤ 30 ng/mL. Predictors of lower 25(OH)D levels included male sex, black or Asian race, and lack of multivitamin use (P<0.001 for each predictor). Seasonal variation in 25(OH)D levels was present in the overall cohort but was not observed in multivitamin users. Lower 25(OH)D levels were associated with increased risk of elevated parathyroid hormone. Regression models predicted 25(OH)D levels ≤ 20 or ≤ 30 ng/mL with areas under the receiver operating characteristic curves of 0.76 and 0.80, respectively. CONCLUSION: Low 25(OH)D levels are prevalent in healthy adults and may confer risk of skeletal disease. Black and Asian adults are at increased risk of deficiency and multivitamin use appears partially protective. Our models predicting low 25(OH)D levels may guide decision-making regarding whom to screen for vitamin D deficiency.
OBJECTIVE:Vitamin D deficiency is highly prevalent in high-risk patient populations, but the prevalence among otherwise healthy adults is less well-defined. The goal of this study was to determine the prevalence and predictors of low 25-hydroxyvitamin D [25(OH)D] levels in healthy younger adults. METHODS: This was a cross-sectional study of 634 healthy volunteers aged 18-50 years performed between January, 2006 and May, 2008. We measured serum 25(OH)D and parathyroid hormone and recorded demographic variables including age, sex, race, and use of multivitamin supplements. RESULTS: Thirty-nine percent of subjects had 25(OH)D ≤ 20 ng/mL and 64% had 25(OH)D ≤ 30 ng/mL. Predictors of lower 25(OH)D levels included male sex, black or Asian race, and lack of multivitamin use (P<0.001 for each predictor). Seasonal variation in 25(OH)D levels was present in the overall cohort but was not observed in multivitamin users. Lower 25(OH)D levels were associated with increased risk of elevated parathyroid hormone. Regression models predicted 25(OH)D levels ≤ 20 or ≤ 30 ng/mL with areas under the receiver operating characteristic curves of 0.76 and 0.80, respectively. CONCLUSION: Low 25(OH)D levels are prevalent in healthy adults and may confer risk of skeletal disease. Black and Asian adults are at increased risk of deficiency and multivitamin use appears partially protective. Our models predicting low 25(OH)D levels may guide decision-making regarding whom to screen for vitamin D deficiency.
Authors: Sherri-Ann M Burnett-Bowie; Benjamin Z Leder; Maria P Henao; Chantel M Baldwin; Douglas L Hayden; Joel S Finkelstein Journal: Clin J Am Soc Nephrol Date: 2012-02-02 Impact factor: 8.237
Authors: Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring Journal: Contemp Clin Trials Date: 2011-10-02 Impact factor: 2.226
Authors: Michael F Holick; Neil C Binkley; Heike A Bischoff-Ferrari; Catherine M Gordon; David A Hanley; Robert P Heaney; M Hassan Murad; Connie M Weaver Journal: J Clin Endocrinol Metab Date: 2011-06-06 Impact factor: 5.958
Authors: Jane A Cauley; Michelle E Danielson; Robert Boudreau; Kamil E Barbour; Mara J Horwitz; Douglas C Bauer; Kristine E Ensrud; JoAnn E Manson; Jean Wactawski-Wende; James M Shikany; Rebecca D Jackson Journal: J Bone Miner Res Date: 2011-10 Impact factor: 6.741
Authors: Anne C Looker; Clifford L Johnson; David A Lacher; Christine M Pfeiffer; Rosemary L Schleicher; Christopher T Sempos Journal: NCHS Data Brief Date: 2011-03
Authors: Pang Yao; Ling Lu; Yao Hu; Gang Liu; Xiafei Chen; Liang Sun; Xingwang Ye; He Zheng; Yan Chen; Frank B Hu; Huaixing Li; Xu Lin Journal: Eur J Nutr Date: 2015-02-19 Impact factor: 5.614
Authors: Deborah M Mitchell; Kristin Ruppert; Nisha Udupa; Fatima Bassir; Karin Darakananda; Daniel H Solomon; Yinjuan Lian; Jane A Cauley; Arun S Karlamangla; Gail A Greendale; Joel S Finkelstein; Sherri-Ann M Burnett-Bowie Journal: Clin Endocrinol (Oxf) Date: 2019-04-24 Impact factor: 3.478
Authors: Anders H Berg; Camille E Powe; Michele K Evans; Julia Wenger; Guillermo Ortiz; Alan B Zonderman; Pirianthini Suntharalingam; Kathryn Lucchesi; Neil R Powe; S Ananth Karumanchi; Ravi I Thadhani Journal: Clin Chem Date: 2015-04-28 Impact factor: 8.327
Authors: Camille E Powe; Michele K Evans; Julia Wenger; Alan B Zonderman; Anders H Berg; Michael Nalls; Hector Tamez; Dongsheng Zhang; Ishir Bhan; S Ananth Karumanchi; Neil R Powe; Ravi Thadhani Journal: N Engl J Med Date: 2013-11-21 Impact factor: 91.245
Authors: Candace Y Parker-Autry; Jonathan L Gleason; Russell L Griffin; Alayne D Markland; Holly E Richter Journal: Int Urogynecol J Date: 2014-05-08 Impact factor: 2.894
Authors: Ivan V Litvinov; Anna Shtreis; Kenneth Kobayashi; Steven Glassman; Matthew Tsang; Anders Woetmann; Denis Sasseville; Niels Ødum; Madeleine Duvic Journal: Oncoimmunology Date: 2016-06-06 Impact factor: 8.110
Authors: M-H Gannagé-Yared; E Helou; V Zaraket; S Abi Akl; L Antonios; M-L Moussalli; S Wakim Journal: J Endocrinol Invest Date: 2014-03-22 Impact factor: 4.256